A seasoned and talented pharmaceutical sales and marketing executive, Sanjiv Sharma has a long track record of optimizing the market performance of new and existing products through shrewd commercial strategy and disciplined implementation. He is President of Inflexionpoint, a consultancy that specializes in developing launch strategy and tactical game plans for companies with limited commercial infrastructure.
His most recent success as a Chief Commercial Officer was the US launch of Diclegis for Duchesnay, one of the top-performing new product launches of 2013, achieved through a highly effective market access initiative and ground-breaking digital strategies. Sanjiv is known for marketing initiatives that deliver “Big Pharma scale” impact on thrifty budgets. His professional history reflects the ability to drive paradigm change using cost-effective and scalable strategies that fully leverage marketing resources, including virtual organization structure, KOL network activation, and skilled application of customer research.
Previously, Sanjiv served as Sr. VP (and US Director) for Nicox, a French-based pharmaceutical platform technology company, and before that, oversaw strategic marketing for Biovail. The prior 15 years were spent with Sanofi-Aventis, where Sanjiv rose from sales rep in Canada to become the Director Global Marketing, New Products Commercialization, Metabolism & Cardiovascular. There, he successfully drove global marketing strategy for Sanofi Aventis’ GLP-1 and its diabetes portfolio.
Sanjiv did his undergraduate work in India and received his MBA with Distinction, from the Richard Ivey School of Business at the University of Western Ontario, Canada.